Site-specific proteasome inhibitors

AF Kisselev - Biomolecules, 2021 - mdpi.com
Proteasome is a multi-subunit protein degradation machine, which plays a key role in the
maintenance of protein homeostasis and, through degradation of regulatory proteins, in the …

Experimental structure based drug design (SBDD) applications for anti‐leishmanial drugs: A paradigm shift?

M Marín, M López, L Gallego‐Yerga… - Medicinal Research …, 2024 - Wiley Online Library
Leishmaniasis is a group of neglected tropical diseases caused by at least 20 species of
Leishmania protozoa, which are spread by the bite of infected sandflies. There are three …

Structure-Guided Design and Synthesis of a Pyridazinone Series of Trypanosoma cruzi Proteasome Inhibitors

MG Thomas, K McGonagle, P Rowland… - Journal of Medicinal …, 2023 - ACS Publications
There is an urgent need for new treatments for Chagas disease, a parasitic infection which
mostly impacts South and Central America. We previously reported on the discovery of …

Small molecules as kinetoplastid specific proteasome inhibitors for leishmaniasis: A patent review from 1998 to 2021

M Imran, SA Khan, Abida, AS Alshrari… - Expert Opinion on …, 2022 - Taylor & Francis
Introduction Leishmaniasis is a neglected tropical infectious disease. The available limited
therapeutic options for leishmaniasis are inadequate due to their poor pharmacokinetic …

Design, synthesis, and optimization of macrocyclic peptides as species-selective antimalaria proteasome inhibitors

H Zhang, J Ginn, W Zhan, YJ Liu, A Leung… - Journal of medicinal …, 2022 - ACS Publications
With over 200 million cases and close to half a million deaths each year, malaria is a threat
to global health, particularly in developing countries. Plasmodium falciparum, the parasite …

Structures revealing mechanisms of resistance and collateral sensitivity of Plasmodium falciparum to proteasome inhibitors

HC Hsu, D Li, W Zhan, J Ye, YJ Liu, A Leung… - Nature …, 2023 - nature.com
The proteasome of the malaria parasite Plasmodium falciparum (Pf20S) is an advantageous
drug target because its inhibition kills P. falciparum in multiple stages of its life cycle and …

Targeting proteasomes in cancer and infectious disease: a parallel strategy to treat malignancies and microbes

JJ Ignatz-Hoover, EV Murphy… - Frontiers in Cellular and …, 2022 - frontiersin.org
Essential core pathways of cellular biology are preserved throughout evolution, highlighting
the importance of these pathways for both bacteria and human cancer cells alike. Cell …

Discovery of highly selective inhibitors of the human constitutive proteasome β5c chymotryptic subunit

W Zhan, D Li, P Saha, R Wang, H Zhang… - Journal of medicinal …, 2023 - ACS Publications
We describe our discovery and development of potent and highly selective inhibitors of
human constitutive proteasome chymotryptic activity (β5c). Structure–activity relationship …

Susceptibilities of Ugandan Plasmodium falciparum isolates to proteasome inhibitors

S Garg, O Kreutzfeld, S Chelebieva… - Antimicrobial agents …, 2022 - Am Soc Microbiol
The proteasome is a promising target for antimalarial chemotherapy. We assessed ex vivo
susceptibilities of fresh Plasmodium falciparum isolates from eastern Uganda to seven …

The AAA+ ATPase p97 as a novel parasite and tuberculosis drug target

G Kobakhidze, A Sethi, S Valimehr, SA Ralph… - Trends in …, 2022 - cell.com
The multifunctional AAA+ ATPase p97 is an unfoldase/segregase involved in various
cellular processes and present in all kingdoms of life. In mammals and yeast, p97 functions …